Zimmer Biomet Holdings (ZBH) Current Assets (2009 - 2026)
Zimmer Biomet Holdings' (ZBH) quarterly Current Assets came in at $5.0 billion in Q1 2026, down 11.23% year-on-year from $5.6 billion in Q1 2025, and down 3.07% quarter-over-quarter from $5.1 billion in Q4 2025.
Zimmer Biomet Holdings (ZBH) Current Assets (2009 - 2026) Analysis & Trends
Zimmer Biomet Holdings' Current Assets history runs 18 years deep, the most recent figure standing at $5.0 billion for Q1 2026.
- On a quarterly basis, Current Assets fell 11.23% year-over-year to $5.0 billion in Q1 2026; TTM through Mar 2026 was $5.0 billion, a 11.23% decrease from a year earlier, with the FY2025 full-year figure at $5.1 billion, up 9.6% from the prior year.
- Current Assets slipped to $5.0 billion in Q1 2026 per ZBH's latest filing, from $5.1 billion in the prior quarter.
- Across five years, Current Assets topped out at $5.8 billion in Q3 2025 and bottomed at $4.4 billion in Q3 2023.
- The 5-year median for Current Assets is $4.6 billion (2024), against an average of $4.8 billion.
- Across the five-year window, Current Assets declined 16.69% in 2022 and advanced 20.7% in 2025, its largest moves.
- Year by year, Current Assets stood at $4.4 billion in 2022, then rose by 4.12% to $4.6 billion in 2023, then grew by 1.35% to $4.7 billion in 2024, then grew by 9.6% to $5.1 billion in 2025, then fell by 3.07% to $5.0 billion in 2026.
- Per Business Quant, the three latest ZBH Current Assets figures stand at $5.0 billion (Q1 2026), $5.1 billion (Q4 2025), and $5.8 billion (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 25.51 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 13.34 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 24.79 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 8.68 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 6.23 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 4.33 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 11.45 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 10.43 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 4.10 Bn |
| 10 | Zimmer Biomet Holdings | 17.48 Bn | 17.07 Bn | 1.51 Bn | 4.96 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.96 Bn |
| Dec 31, 2025 | 5.12 Bn |
| Sep 30, 2025 | 5.83 Bn |
| Jun 30, 2025 | 5.05 Bn |
| Mar 31, 2025 | 5.59 Bn |
| Dec 31, 2024 | 4.67 Bn |
| Sep 30, 2024 | 4.86 Bn |
| Jun 30, 2024 | 4.64 Bn |
| Mar 31, 2024 | 4.63 Bn |
| Dec 31, 2023 | 4.61 Bn |
| Sep 30, 2023 | 4.37 Bn |
| Jun 30, 2023 | 4.39 Bn |
| Mar 31, 2023 | 4.41 Bn |
| Dec 31, 2022 | 4.43 Bn |
| Sep 30, 2022 | 4.53 Bn |
| Jun 30, 2022 | 4.46 Bn |
| Mar 31, 2022 | 4.52 Bn |
| Dec 31, 2021 | 4.89 Bn |
| Sep 30, 2021 | 5.31 Bn |
| Jun 30, 2021 | 5.36 Bn |